1
Views
12
CrossRef citations to date
0
Altmetric
Research Article

cis-Acting Translational Effects of the 5′ Noncoding Region of c-myc mRNA

, , &
Pages 2875-2883 | Received 16 Oct 1987, Accepted 01 Apr 1988, Published online: 31 Mar 2023

LITERATURE CITED

  • Adams, J. M., S. Gerondakis, E. Webb, L. M. Corcoran, and S. Cory. 1983. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc. Natl. Acad. Sci. USA 80:1982–1986.
  • Adams, J. M., A. N. Harris, C. A. Pinkert, L. M. Corcoran, N. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (London) 318:533–538.
  • Baim, S. B., D. F. Pietras, D. C. Eustice, and F. Sherman. 1985. A mutation allowing an mRNA secondary structure diminishes translation of Saccharomyces cerevisiae iso-l-cytochrome c. Mol. Cell. Biol. 5:1839–1846.
  • Bernard, O., S. Cory, S. Gerondakis, E. Webb, and J. M. Adams. 1983. Sequence of the murine and human cellular myc oncogenes and two modes of transcription resulting from chromosome translocation in B lymphoid tumors. EMBO J. 2:2375–2383.
  • Bishop, J. M. 1987. The molecular genetics of cancer. Science 235:305–311.
  • Butnick, N. Z., C. Miyamoto, R. Chizzonite, B. R. Cullen, G. Ju, and A.-M. Skalka. 1985. Regulation of human c-myc gene: 5′ noncoding sequences do not affect translation. Mol. Cell. Biol. 5:3009–3016.
  • Colman, A. 1984. Expression of exogenous DNA in Xenopus oocytes, p. 49–69. In B. D. Hames and S. J. Higgins (ed.), Transcription and translation: a practical approach. IRL Press Ltd., Oxford.
  • Colman, A. 1984. Translation of eukaryotic messenger RNA in Xenopus oocytes, p. 271–302. In B. D. Hames and S. J. Higgins (ed.), Transcription and translation: a practical approach. IRL Press Ltd., Oxford.
  • Corcoran, L. M., S. Cory, and J. M. Adams. 1985. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a mouse plasmacytoma. Cell 40:71–79.
  • Cory, S. 1986. Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv. Cancer Res. 47:189–234.
  • Dani, C., J. M. Blanchard, M. Piechaczyk, S. El Sabouty, L. Marty, and P. Jeanteur. 1984. Extreme instability of myc mRNA in normal and transformed human cells. Proc. Natl. Acad. Sci. USA 81:7046–7050.
  • Dani, C., N. Mechti, M. Piechaczyk, B. Lebleu, P. Jeanteur, and J. M. Blanchard. 1985. Increased rate of degradation of c-myc in interferon-treated Daudi cells. Proc. Natl. Acad. Sci. USA 82:4896–4899.
  • Darveau, A., J. Pelletier, and N. Sonenberg. 1985. Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5′ untranslated region. Proc. Natl. Acad. Sci. USA 82:2315–2319.
  • Eisenman, R. N., C. Y. Tachibana, H. D. Abrams, and S. R. Hann. 1985. v-myc- and c-myc-encoded proteins are associated with the nuclear matrix. Mol. Cell. Biol. 5:114–126.
  • Erikson, J., D. A. Miller, O. J. Miller, P. W. Abcarian, R. M. Skurla, J. F. Mushinski, and C. M. Croce. 1985. The c-myc oncogene is translocated to the involved chromosome 12 in mouse plasmacytoma. Proc. Natl. Acad. Sci. USA 82:4212–4216.
  • Fahrlander, P. D., J. Sümegi, J.-Q. Yang, F. Weiner, K. B. Marcu, and G. Klein. 1985. Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma. Proc. Natl. Acad. Sci. USA 82:3746–3750.
  • Godeau, F., H. Persson, H. E. Gray, and A. B. Pardee. 1986. c-myc expression is dissociated from DNA synthesis and cell division in Xenopus oocyte and early embryonic development. EMBO J. 5:3571–3577.
  • Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
  • Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:465–467.
  • Hann, S. R., and R. N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486–2497.
  • Hann, S. R., M. W. King, D. L. Bentley, C. W. Anderson, and R. N. Eisenman. 1988. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell 52:185–195.
  • Jones, T. R., and M. D. Cole. 1987. Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3′ untranslated sequences. Mol. Cell. Biol. 7:4513–4521.
  • Kaufman, R. 1985. Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors. Proc. Natl. Acad. Sci. USA 82:689–693.
  • Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
  • Krieg, P. A., and D. A. Melton. 1984. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res. 12:7057–7070.
  • Lachman, H. M., and H. I. Skoultchi. 1984. Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature (London) 310:592–594.
  • Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680–685.
  • Land, H., A. C. Chen, J. P. Morgenstern, L. F. Parada, and R. A. Weinberg. 1986. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 6:1917–1925.
  • Land, H., L. Parada, and R. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304:596–602.
  • Leder, P., J. Battey, G. Lenoir, C. Moulding, W. Murphy, H. Potter, T. Stewart, and R. Taub. 1983. Translocation among antibody genes in human cancer. Science 222:765–771.
  • Lee, K. A. W., and N. Sonenberg. 1982. Inactivation of capbinding proteins accompanies the shut-off of host protein synthesis by poliovirus. Proc. Natl. Acad. Sci. USA 79:3447–3451.
  • Lombardi, L., E. W. Newcomb, and R. Dalla Favera. 1987. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 49:161–170.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Marcu, K. B., L. J. Harris, L. W. Stanton, J. Erikson, R. Watt, and C. M. Croce. 1983. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocation in B cell neoplasia. Proc. Natl. Acad. Sci. USA 80:519–523.
  • McGarry, T. J., and S. Lindquist. 1985. The preferential translation of Drosophila hsp70 mRNA requires sequences in the untranslated leader. Cell 42:903–911.
  • Mellon, P., V. Parker, Y. Gluzman, and T. Maniatis. 1981. Identification of DNA sequences required for transcription of the human α1-globin gene in a new SV40 host-vector system. Cell 27:279–288.
  • Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035–7056.
  • Nepveu, A., K. B. Marcu, A. I. Skoultchi, and H. M. Lachman. 1987. Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells. Genes Dev. 1:938–945.
  • Nilsen, T. W., and P. A. Maroney. 1984. Translational efficiency of c-myc mRNA in Burkitt lymphoma cells. Mol. Cell. Biol. 4:2235–2238.
  • Pelham, H. P. B., and R. J. Jackson. 1976. An efficient mRNA dependent translation system from reticulocyte lysates. Eur. J. Biochem. 67:247–256.
  • Pelletier, J., and N. Sonenberg. 1985. Insertion mutagenesis to increase secondary structure within the 5′ noncoding region of a eucaryotic mRNA reduces translational efficiency. Cell 40:515–526.
  • Persson, H., and P. Leder. 1984. Nuclear localization and DNA binding properties of protein expressed by human c-myc oncogene. Science 225:718–721.
  • Piechaczyk, M., J.-M. Blanchard, and P. Jeanteur. 1987. c-myc gene regulation still holds its secret. Trends Genet. 3:47–51.
  • Piechaczyk, M., W.-J. Yang, J.-M. Blanchard, P. Jeanteur, and K. B. Marcu. 1985. Post-transcriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors. Cell 42:589–597.
  • Rabbitts, P. H., A. Forster, M. A. Stinson, and T. H. Rabbitts. 1985. Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNA stability. EMBO J. 4:3727–3733.
  • Ramsay, G., G. I. Evan, and J. M. Bishop. 1984. The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA 81:7742–7746.
  • Rose, J. K., H. Trachsel, K. Leong, and D. Baltimore. 1978. Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc. Natl. Acad. Sci. USA 75:2732–2736.
  • Saito, H., A. C. Hayday, K. Wiman, W. S. Hayward, and S. Tonegawa. 1983. Activation of the c-myc gene by translocation: a model for translational control. Proc. Natl. Acad. Sci. USA 80:7476–7480.
  • Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697–1709.
  • Taub, R., C. Moulding, J. Battey, W. Murphy, T. Vasicek, G. M. Lenoir, and P. Leder. 1984. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells. Cell 36:339–348.
  • Taylor, M. V., M. Guzze, G. I. Evan, N. Dathan, and M. Mechali. 1986. Xenopus myc proto-oncogene during development: expression as a stable maternal mRNA uncoupled from cell division. EMBO J. 5:3563–3570.
  • Watt, R., L. W. Stanton, K. B. Marcu, R. C. Gallo, C. M. Croce, and G. Rovera. 1983. Nucleotide sequence of cloned cDNA of human c-myc oncogene. Nature (London) 303:725–728.
  • Watt, R. A., A. R. Shatzman, and M. Rosenberg. 1985. Expression and characterization of the human c-myc DNA-binding protein. Mol. Cell. Biol. 5:448–456.
  • Wiman, K. G., B. Clarkson, A. C. Hayday, H. Saito, S. Tonegawa, and W. S. Hayward. 1984. Activation of a translocated c-myc gene: role of structural alterations in the upstream region. Proc. Natl. Acad. Sci. USA 81:6798–6802.
  • Yang, J.-Q., E. Remmers, and K. Marcu. 1986. The first exon of the c-myc proto-oncogene contains a novel positive control element. EMBO J. 5:3553–3562.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.